Pricing Log in Create free account
Saturday 17 October 2026 Export PAHC’s income statement to Excel — free account

Phibro Animal Health Corporation

PAHC Healthcare Drug Manufacturers Specialty & Generic

Phibro Animal Health Corporation’s revenue for fiscal 2026 (year ended June 2026) was $1.5 billion, up 17.1% from fiscal 2025. In the quarter to June 2026, revenue grew 4.77%, EPS grew 28.6%, free cash flow fell 35.7% and total debt rose 1.96%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

38.82 0.84 +2.21%
Market cap
$1.5B
P/E
15.8×
Fwd P/E
11.1×
Dividend yield
1.24%
F-score
6/9
Altman Z
2.95
Beneish M
−2.39
Dividend safety
47/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Phibro Animal Health Corporation (PAHC) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Phibro Animal Health Corporation (PAHC) trades at a P/E ratio of 15.8×. Over the past ten years it has ranged from 8.8× (June 2016) to 374× (September 2024); the current reading is higher than 20% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 19.2× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 12.8× (40.53%)
FY2025 21.5× (92.44%)
FY2024 284× 1,579.12%
FY2023 16.9× 6.98%
FY2022 15.8× (26.64%)
FY2021 21.6× (32.73%)
FY2020 32.0× 37.79%
FY2019 23.3× (20.10%)
FY2018 29.1× 28.81%
FY2017 22.6× 155.46%

Quarterly newest first

Period P/E ratio Change
Jun 2026 12.8× (46.00%)
Mar 2026 23.6× 43.62%
Dec 2025 16.5× (32.07%)
Sep 2025 24.2× 12.88%
42 more quarters

Against its own ten years

Low 8.8× High 374×
Ten-year median 21.2×
Current reading's percentile 22

P/E ratio against peers

Company P/E ratio
XERS Xeris Biopharma Holdings, Inc. compare n/m
BCRX BioCryst Pharmaceuticals, Inc. compare n/m
ALVO Alvotech compare n/m
AMPH Amphastar Pharmaceuticals, Inc. compare 14.9×
ANIP ANI Pharmaceuticals, Inc. compare 14.9×
PAHC Phibro Animal Health Corporation 15.8×
CRON Cronos Group Inc. compare 16.1×
PCRX Pacira BioSciences, Inc. compare 104×
ETON Eton Pharmaceuticals, Inc. compare 107×
Drug Manufacturers Specialty & Generic industry median 19.2×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on PAHC